Patient-Funded Trials: Opportunity or Liability?

, &
Cell Stem Cell 17 (2):135-137 (2015)
  Copy   BIBTEX

Abstract

Patient-funded trials are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols

Categories

Keywords

Reprint years

Links

PhilArchive

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Qualification of Pre-Contractual Liability and the Value of Lost Opportunity as a Form of Losses.Julija Kiršienė & Natalja Leonova - 2009 - Jurisprudencija: Mokslo darbu žurnalas 115 (1):221-246.
A developing country response to Lavery et al. "In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?".Douglas R. Wassenaar & Gita Ramjee - 2009 - BMC Medical Ethics 10 (1):16-.
Do physicians' legal duties to patients conflict with public health values? The case of antibiotic overprescription.Carl H. Coleman - 2009 - Journal of Bioethical Inquiry 6 (2):181-185.
Beyond Access vs. Protection in Trials of Innovative Therapies.Alex John London, Jonathan Kimmelman & Marina Elena Emborg - unknown
Clinical trials--a brave new partnership?H. Thornton - 1994 - Journal of Medical Ethics 20 (1):19-25.
End of Life Pediatric Research: What About the Ethics? [REVIEW]Danielle Laudy - 2009 - Journal of Academic Ethics 7 (1-2):87-91.
A Study in Contrasts: Eligibility Criteria in a Twenty-Year Sample of NSABP and POG Clinical Trials.Abraham Fuks, Charles Weijer, Benjamin Freedman, Stanley Shapiro, Myriam Skrutkowska & Amina Riaz - unknown
Patient-funded research: paying the piper or protecting the patient?E. Haavi Morreim - 1990 - IRB: Ethics & Human Research 13 (3):1-6.
Polishing Up the Pinto.John R. Danley - 2005 - Business Ethics Quarterly 15 (2):205-236.
Some Popular Versions of Uninformed Consent.Jane L. Hutton & Richard E. Ashcroft - 2000 - Health Care Analysis 8 (1):41-53.
Palliative care and cancer trials.S. M. Brown - 2003 - Journal of Medical Ethics 29 (6):371-371.
The IRB's Role in Assessing the Generalizability of Non-NIH-Funded Clinical Trials.Charles Weijer - 1998 - IRB: Ethics & Human Research 20 (2/3):1.
How to Resolve an Ethical Dilemma Concerning Randomized Clinical Trials.Don Marquis - unknown
Disputing the ethics of research: The challenge from bioethics and patient activism to the interpretation of the declaration of helsinki in clinical trials.Simon Woods & Pauline Mccormack - 2012 - Bioethics 27 (5):243-250.
The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.H. Weijer - 1998 - IRB: Ethics & Human Research 20 (2-3):1.

Analytics

Added to PP
2015-10-16

Downloads
447 (#43,909)

6 months
58 (#80,507)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Alex John London
Carnegie Mellon University
Danielle M. Wenner
Carnegie Mellon University

Citations of this work

Donor-funded research: permissible, not perfect.Mike King & Angela Ballantyne - 2019 - Journal of Medical Ethics 45 (1):36-40.

Add more citations

References found in this work

Add more references